Adjuvant Entecavir or Tenofovir for Postoperative HBV-HCC

NCT02650271 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Entecavir
DRUG: Tenofovir

Sponsor

Guangxi Medical University